Amundi Sells 172,971 Shares of Doximity, Inc. (NASDAQ:DOCS)

Amundi cut its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 93.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,656 shares of the company’s stock after selling 172,971 shares during the quarter. Amundi’s holdings in Doximity were worth $641,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in DOCS. Shaker Investments LLC OH acquired a new position in Doximity in the 4th quarter valued at approximately $559,000. Penserra Capital Management LLC acquired a new stake in shares of Doximity during the third quarter worth $2,384,000. Principal Financial Group Inc. increased its position in shares of Doximity by 1.5% during the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company’s stock worth $15,695,000 after buying an additional 4,282 shares during the period. Newbridge Financial Services Group Inc. acquired a new stake in shares of Doximity during the fourth quarter worth $362,000. Finally, Stratos Wealth Partners LTD. acquired a new stake in shares of Doximity during the fourth quarter worth $203,000. 87.19% of the stock is owned by institutional investors.

Doximity Price Performance

NASDAQ:DOCS opened at $62.84 on Friday. The company has a market capitalization of $11.73 billion, a PE ratio of 62.84, a P/E/G ratio of 4.10 and a beta of 1.34. The firm’s 50-day moving average price is $64.20 and its 200-day moving average price is $53.21. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $85.21.

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 37.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on DOCS shares. Mizuho increased their price objective on shares of Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Wells Fargo & Company reaffirmed an “equal weight” rating on shares of Doximity in a research note on Friday, February 7th. Leerink Partnrs raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 7th. Needham & Company LLC raised their price objective on shares of Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Finally, Canaccord Genuity Group raised their price objective on shares of Doximity from $60.00 to $71.00 and gave the company a “hold” rating in a research note on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $64.22.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.